Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 07-2008 | 04-2008 | 01-2008 | 10-2007 | 07-2007 | |
| Sales | 381,800 | 393,200 | 329,100 | 284,100 | 346,100 |
| Cost of Goods | 251,200 | 251,700 | 208,700 | 170,400 | 232,500 |
| Gross Profit | 130,600 | 141,500 | 120,400 | 113,700 | 113,600 |
| Operating Expenses | 105,000 | 108,400 | 103,100 | 92,100 | 99,700 |
| Operating Income | 25,800 | 33,800 | 18,000 | 22,000 | 14,400 |
| Other Income | -9,500 | -15,900 | -44,900 | -21,500 | 5,000 |
| Pre-tax Income | 16,300 | 17,900 | -26,900 | 500 | 19,400 |
| Income Tax | 2,900 | 1,900 | 1,500 | -2,500 | 2,000 |
| Net Income Continuous | 13,400 | 16,000 | -28,400 | 3,000 | 17,400 |
| Net Income Discontinuous | 1,700 | 300 | 1,100 | -9,000 | -800 |
| Net Income | $15,100 | $16,300 | $-27,300 | $-6,000 | $16,600 |
| EPS Basic Total Ops | 0.13 | 0.14 | -0.23 | -0.05 | 0.14 |
| EPS Basic Continuous Ops | 0.11 | 0.14 | -0.24 | 0.02 | 0.15 |
| EPS Basic Discontinuous Ops | 0.02 | 0.00 | 0.01 | -0.07 | -0.01 |
| EPS Diluted Total Ops | 0.13 | 0.14 | -0.23 | 0.02 | 0.14 |
| EPS Diluted Continuous Ops | 0.11 | 0.14 | -0.24 | 0.08 | 0.15 |
| EPS Diluted Discontinuous Ops | 0.02 | 0.00 | 0.01 | -0.06 | -0.01 |
| EBITDA(a) | $89,000 | $54,900 | $-24,600 | $57,300 | $66,900 |